Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats. 2009

Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
Department of Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. mkozer1971@yahoo.com

The nephrotoxicity of amikacin (AK) was prevented with pentoxifylline (PTX) in a rat model. Rats were received a single injection of AK (1.2 g/kg, i.p.) with or without PTX pretreatment (25 mg/kg, orally). Renal morphology was investigated by light microscopy. Tissue samples and trunk blood were also obtained to determine renal malondialdehyde (MDA), blood urea nitrogen (BUN), and creatinine (Cr) levels. MDA production was found to be higher in AK group. PTX administration caused a significant decrease in MDA production. Morphological damage in rats given AK was severe in the kidney, whereas in rats given AK plus PTX, no histological changes occurred. It is concluded that PTX could be useful for reducing the nephrotoxic effects of AK.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D010431 Pentoxifylline A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. Agapurin,BL-191,Oxpentifylline,Pentoxil,Torental,Trental,BL 191,BL191
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
January 2009, Renal failure,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
January 2013, Renal failure,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
January 2012, American journal of otolaryngology,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
April 2000, Indian journal of experimental biology,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
May 1997, Clinical and experimental pharmacology & physiology,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
January 2006, Cell biochemistry and function,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
August 2018, Ear, nose, & throat journal,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
August 2004, Urological research,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
June 1986, Pathologie-biologie,
Mehmet Kaya Ozer, and Halil Asci, and Meral Oncu, and Sukriye Yesilot, and Mehtap Savran, and Dilek Bayram, and Ekrem Cicek
November 2023, AMB Express,
Copied contents to your clipboard!